ClinicalTrials.gov
public full text
Public Domain
Study of IBI3016 in People With Mild or Moderate Hypertension Patients
A Phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics, and pharmacodynamic characteristics of a single subcutaneous dose of IBI3016 in Chinese patients with mild to moderate hypertension.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of IBI3016 in Japanese Participants#1164744
- A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients#879753
- A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants#860744
- Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants#867049
- Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell Carcinoma#917108
Record · ID 1164844
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive